BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

Cytox

Cytox logo

Founded
2004
Geography
United Kingdom based
Funding
$15.573 M

Cytox Group Limited provides non-invasive, risk assessment and patient stratification tools for Alzheimer's disease and dementia. Cytox’s mission is to transform how new treatments are developed, people are screened, and how patients are managed within the Alzheimer’s disease care pathway..

Technologies

AI Companies (Drug Discovery)  

R&D Platform

Cytox’s aim is to identify genetic risk variants, or single nucleotide polymorphisms (SNPs), which can be used ultimately, in the definition of an algorithm to predict AD progression.


genoSCORE

Read more

genoTOR

Read more

Pipelines

No pipelines published yet

Products

 

Services

No services posted yet